Healthcare stocks such as AbbVie, Eli Lilly and Johnson & Johnson surged to near‑record levels as investors sold technology holdings. The rotation indicates a change in risk appetite, with investors favoring defensive sectors and potentially reshaping sector‑level capital flows. AbbVie, Eli Lilly, Johnson & Johnson, institutional and retail investors rotating out of tech. Continued inflows into healthcare if tech weakness persists; watch for earnings reports and any policy shifts affecting drug pricing. Shares of AbbVie, Eli Lilly and Johnson & Johnson are approaching all‑time highs, signaling a renewed appetite for the biopharmaceutical sector. The move comes as market participants rotate out of technology equities, seeking defensive exposure amid uncertain growth prospects. While the shift reflects short‑term sentiment, it also highlights the relative stability healthcare offers during periods of market volatility.
INTELLIGENCE
Social Pulse
AI estimate · not scraped